Non‐Telomeric Role of RAP1 in Facilitating NF ‐ κ B Activation and Driving Hepatocellular Carcinoma Progression
IUBMB Life · 2026-07 · 78 (7)
DOI: 10.1002/iub.70123 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, online erschienen am 15.07.2026. Verfasst von Rui Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Telomere-Binding Proteins, NF-kappa B. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Tianjin Health Research Project, Joint Funds of the Natural Science Foundation of Tianjin, Youth Innovation Talents Training Project of Tianjin First Central Hospital.
Abstract (Originalsprache)
RAP1 (TERF2IP) is a component of the shelterin complex that protects telomeric DNA and preserves chromosome stability. In addition to its telomeric function, accumulating evidence indicates that mammalian RAP1 also exerts multiple extra‐telomeric functions. Notably, RAP1 has been reported to regulate the NF‐ κ B signaling pathway and to function as a transcriptional regulator, suggesting potential roles in tumorigenesis. In this study, we found that RAP1 expression was significantly upregulated in hepatocellular carcinoma (HCC) cells. Functional analyses demonstrated that RAP1 promoted malignant phenotypes in HCC through a non‐telomeric mechanism. In cellular models, RAP1 overexpression enhanced cell proliferation while suppressing senescence and apoptosis, whereas RAP1 knockdown produced the opposite effects. Mechanistically, RAP1 functioned as an upstream activator of the NF‐ κ B signaling cascade, resulting in increased phosphorylation of the p65 subunit and upregulation of downstream targets, including IL‐1β and BCL‐2 . Importantly, the oncogenic activity of RAP1 was shown to be dependent on NF‐ κ B signaling in vivo, as pharmacological inhibition of NF‐ κ B significantly suppressed RAP1‐driven tumor growth in a xenograft model. Collectively, these findings reveal a previously unrecognized role for RAP1 in promoting HCC progression through activation of NF‐ κ B signaling and identify the RAP1/NF‐ κ B axis as a potential therapeutic target for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, China.
- Gastroenterology Department, Children's Hospital, Tianjin University (Tianjin Children's Hospital), Tianjin, China.
Förderung
- Tianjin Health Research Project
- Joint Funds of the Natural Science Foundation of Tianjin
- Youth Innovation Talents Training Project of Tianjin First Central Hospital
Zitieren
APA
Liu, R., Fu, N., Li, S., & Liu, T. (2026). Non‐Telomeric Role of RAP1 in Facilitating NF ‐ κ B Activation and Driving Hepatocellular Carcinoma Progression. IUBMB Life, 78(7). https://doi.org/10.1002/iub.70123
Vancouver
Liu R, Fu N, Li S, Liu T. Non‐Telomeric Role of RAP1 in Facilitating NF ‐ κ B Activation and Driving Hepatocellular Carcinoma Progression. IUBMB Life. 2026;78(7). doi:10.1002/iub.70123
BibTeX
@article{Liu2026,
author = {Liu, Rui and Fu, Nannan and Li, Shuang and Liu, Tao},
title = {Non‐Telomeric Role of RAP1 in Facilitating NF ‐ κ B Activation and Driving Hepatocellular Carcinoma Progression},
journal = {IUBMB Life},
year = {2026},
volume = {78},
number = {7},
doi = {10.1002/iub.70123}
}
EUVIMED